These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38006229)

  • 1. Pyrogallol experimentally and theoretically suppressed advanced glycation end products (AGEs) formation, as one of the mechanisms involved in the chronic complications of the diabetes.
    Dorali Beni A; Bahramikia S
    J Asian Nat Prod Res; 2024 Jun; 26(6):726-738. PubMed ID: 38006229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced Glycation End Products Modulate Structure and Drug Binding Properties of Albumin.
    Awasthi S; Murugan NA; Saraswathi NT
    Mol Pharm; 2015 Sep; 12(9):3312-22. PubMed ID: 26281017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
    Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
    Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bimolecular interaction of argpyrimidine (a Maillard reaction product) in in vitro non-enzymatic protein glycation model and its potential role as an antiglycating agent.
    Bhattacherjee A; Dhara K; Chakraborti AS
    Int J Biol Macromol; 2017 Sep; 102():1274-1285. PubMed ID: 28487198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2'-Deoxyribose Mediated Glycation Leads to Alterations in BSA Structure Via Generation of Carbonyl Species.
    Rafi Z; Alouffi S; Khan MS; Ahmad S
    Curr Protein Pept Sci; 2020; 21(9):924-935. PubMed ID: 32053073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The noncovalent conjugations of bovine serum albumin with three structurally different phytosterols exerted antiglycation effects: A study with AGEs-inhibition, multispectral, and docking investigations.
    Sobhy R; Zhan F; Mekawi E; Khalifa I; Liang H; Li B
    Bioorg Chem; 2020 Jan; 94():103478. PubMed ID: 31806157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentosidine in advanced glycation end-products (AGEs) during UVA irradiation generates active oxygen species and impairs human dermal fibroblasts.
    Okano Y; Masaki H; Sakurai H
    J Dermatol Sci; 2001 Aug; 27 Suppl 1():S11-8. PubMed ID: 11514120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-resolved and steady-state fluorescence spectroscopic studies of the human lens with comparison to argpyrimidine, pentosidine and 3-OH-kynurenine.
    Kessel L; Kalinin S; Nagaraj RH; Larsen M; Johansson LB
    Photochem Photobiol; 2002 Nov; 76(5):549-54. PubMed ID: 12462652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence.
    Ahmed N; Thornalley PJ
    Biochem J; 2002 May; 364(Pt 1):15-24. PubMed ID: 11988071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products and oxidative stress are increased in chronic allograft nephropathy.
    Raj DS; Lim G; Levi M; Qualls C; Jain SK
    Am J Kidney Dis; 2004 Jan; 43(1):154-60. PubMed ID: 14712439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatographic quantification of argpyrimidine, a methylglyoxal-derived product in tissue proteins: comparison with pentosidine.
    Wilker SC; Chellan P; Arnold BM; Nagaraj RH
    Anal Biochem; 2001 Mar; 290(2):353-8. PubMed ID: 11237339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creatine plays a direct role as a protein modifier in the formation of a novel advanced glycation end product.
    Miyazaki K; Nagai R; Horiuchi S
    J Biochem; 2002 Oct; 132(4):543-50. PubMed ID: 12359068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
    Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
    Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coffee leaf extract inhibits advanced glycation end products and their precursors: A mechanistic study.
    Sun Y; Xie W; Huang Y; Chen X
    J Food Sci; 2024 Jun; 89(6):3455-3468. PubMed ID: 38700315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
    Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
    Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive skin autofluorescence, blood and urine assays of the advanced glycation end product (AGE) pentosidine as an indirect indicator of AGE content in human bone.
    Kida Y; Saito M; Shinohara A; Soshi S; Marumo K
    BMC Musculoskelet Disord; 2019 Dec; 20(1):627. PubMed ID: 31881872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of pentosidine and pyrraline in food and chemical models: formation, potential risks and determination.
    Li H; Yu SJ
    J Sci Food Agric; 2018 Jul; 98(9):3225-3233. PubMed ID: 29280151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridoxamine inhibits maillard reactions in diabetic rat lenses.
    Padival S; Nagaraj RH
    Ophthalmic Res; 2006; 38(5):294-302. PubMed ID: 16974131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational investigation of inhibitory mechanism of flavonoids as bovine serum albumin anti-glycation agents.
    Johari A; Moosavi-Movahedi AA; Amanlou M
    Daru; 2014 Dec; 22(1):79. PubMed ID: 25498599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DAF in diabetic patients is subject to glycation/inactivation at its active site residues.
    Flückiger R; Cocuzzi E; Nagaraj RH; Shoham M; Kern TS; Medof ME
    Mol Immunol; 2018 Jan; 93():246-252. PubMed ID: 28886871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.